Mirador Therapeutics
Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases
$250MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases
Develops medicines targeting historically undruggable protein targets in cancer
Pitching Farallon Capital Management? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room